← Leaderboards
Alexei Yurievitch Savinov
Sanford Research/Usd
$2,122,638
Attributed
$3,131,493
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,131,493 · 5
By mechanism
R44$1,617,711 · 1
P20$1,213,782 · 3
R56$300,000 · 1
Top collaborators
- Hua Wu3 shared
- Midhat H Abdulreda1 shared
- Clayton E Mathews1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseFundingEnsureAreaPreparationData AnalysesDesignFuturePhenotypeTranslatingT-LymphocytePersonsAntigensInsulin-Dependent Diabetes MellitusRegulatory T-LymphocyteCell SeparationBindingSuccessAutoimmunityData CollectionConsultCancer BiologyComputer Software
Grant awards (11)
Engineering Human T Regulatory Cells with Chimeric Antigen Receptor Targeting NTPDase3 on the Surface of β cells for Type 1 Diabetes Control$300,000
R56 · FY2024 · AI · contact PI
Construction of functional human CAR recognizing live pancreatic beta cells$298,988
P20 · FY2022 · GM · contact PI
Construction of functional human CAR recognizing live pancreatic beta cells$73,879
P20 · FY2021 · GM · contact PI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$418,106
R44 · FY2020 · AI
Flow Cytometry Core$168,183
P20 · FY2020 · GM · contact PI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$1,000,000
R44 · FY2019 · AI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$199,605
R44 · FY2019 · AI
Flow Cytometry Core$168,183
P20 · FY2019 · GM · contact PI
Flow Cytometry Core$168,183
P20 · FY2018 · GM · contact PI
Flow Cytometry Core$168,183
P20 · FY2017 · GM · contact PI
Flow Cytometry Core$168,183
P20 · FY2016 · GM · contact PI